The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise

Tue, 25th May 2021 17:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Webis Holdings PLC - Isle of Man-based gaming firm - Receives West Virginia wagering license which allows company to accept online wagers from state residents. "We are delighted to receive this license from the West Virginia Racing Commission for WatchandWager. We believe that this license will be mutually beneficial to both the company and the state in the forms of revenue and taxes generated from wagering," says Webis.

----------

Revolution Bars Group PLC - bars operator based in Ashton-under-Lyne, England - Intends to raise GBP21.0 million via a firm placing, placing and an open offer at 20 pence per share. Says proceeds will go towards indebtedness, accelerate its existing site refurbishment programme and to take advantage of favourable market conditions for estate expansion.

----------

JPMorgan Global Core Real Assets Ltd - real estate, transportation and infrastructure investor - Says further USD13.8 million of committed capital called, with a funding date no later than June 7. "This capital is being called by the Asia-Pacific Real Estate Strategy and materially increases the exposure to industrial/ logistics assets within the property allocation," says JPMorgan Global Core. Says it has now invested 96% of the total capital raised from proceeds of both the IPO and all subsequent share issuance.

----------

Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Says the first patient with secondary progressive multiple sclerosis was dosed with nasally administered Foralumab, a fully human anti-CD3 monoclonal antibody. Says this is the first-ever clinical study in SPMS patients, under an individual patient expanded access IND, and will continue for six months to evaluate routine safety, tolerability, and neurological behaviors. "Effective and targeted treatments for progressive MS are urgently needed. Nasal Foralumab could revolutionize treatment for this disabling form of disease," says Tanuja Chitnis, professor of neurology at Harvard Medical School.

----------

Mothercare PLC - Hemel Hempstead, England-based retailer to parents and young children - Reports unaudited net worldwide sales of GBP326 million for the year to March 27, down 40% to a year prior, impacted by varied approaches to Covid-19 in franchisee markets. "As a global brand the impact of Covid-19 has varied enormously by market as the countries in which our franchise partners operate have addressed the Covid-19 pandemic in many different ways including, but not limited to, restrictions on travel, movement and operating hours of retailers. These issues have been compounded by similar restrictions for our manufacturing partners, which coupled with the disruption to the global movement of freight, have caused additional challenges with availability of product for franchise partners further impacting sales for the year," says Mothercare. Expects to report a "small" earnings before interest, depreciation and amortisation profit for the year. Sees annual operating profit of GBP15 million "in future years" .

----------

Custodian REIT PLC - Leicester, England-based commercial real estate investor - Sells retail unit in Nottingham at auction for GBP700,000, in line with the most recent valuation. Says the disposal has reduced the Company's high street retail sector weighting by income from 10% to 9%. "This asset was not aligned with the strategy of the Company as we did not anticipate future rental recovery," says Custodian.

----------

Baillie Gifford UK Growth Fund PLC - investment firm focused on capital growth over the long-term from investment primarily in shares of listed UK companies - Announces name change to Baillie Gifford UK Growth Trust, effective Wednesday. The trading symbol and ISIN are to stay the same.

----------

Octopus Titan VCT PLC - venture capital trust - Announces that terms have been agreed for Snap Inc to acquire WaveOptics Ltd "at a value not materially different from its holding value". WaveOptics is a business that designs and sells a set of components for use in augmented reality glasses that allow for the creation of AR displays. Titan gas invested around GBP16.0 million in WaveOptics.

----------

IronRidge Resources Ltd - Australia-based minerals exploration company - Reports additional broad and high-grade lithium pegmatite drill intersections at new targets adjacent to the Ewoyaa lithium project in Ghana. "We are highly encouraged with the ongoing results received, which continue to confirm additional high grades in new exploration targets tested within the ELP area," says IronRidge.

----------

Sareum Holdings PLC - Cambridge-based drug development firm - Says Covid-19 continues to impact the contract research organisations with which Sareum is working to complete the preclinical development of SDC-1801 for autoimmune disease. "While initially the impact on development timelines was minimal, it has increased and is causing further delays to the conduct of the final preclinical studies the company needs to complete on SDC-1801 prior to filing an exploratory Clinical Trial Application," says Sareum. Says it now expects final toxicity and safety studies to complete in the third quarter of the year.

----------

Epwin Group PLC - Solihull, England-based building products manufacturer - Says demand from the group's key markets continues to be high, with indicators of consumer confidence strengthening. Revenue for the first four months of the year are 56% ahead of 2020, which included the first lockdown period, and 9% ahead of 2019. "The outlook for the current year continues to be favourable, notwithstanding the raw material cost inflation and supply chain issues, which we are managing proactively. The medium and long-term drivers for the Group's markets also remain positive, with a shortage of housing, an ageing and underinvested housing stock, as well as environmental and safety concerns driving legislation and initiatives that will require improvements to homes on a larger scale than just essential maintenance," says Epwin.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Feb 2019 11:40

Tiziana Life Sciences Non-Exec Director Riccardo Dalla-Favera Resigns

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday said Non-Executive Director Riccardo Dalla-Favera has resigned from his role."The company is grateful to Favera for his

Read more
3 Dec 2018 14:27

Tiziana completes patient enrolment in ongoing Milciclib study

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that patient enrolment in its ongoing Phase 2a clinical trial, known as CDKO-125A-010, was now completed.

Read more
3 Dec 2018 11:51

Tiziana Life Completes Patient Enrollment In Liver Cancer Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday said it completed patient enrollment in a Phase 2a trial of Milciclib in hepatocellular carcinoma.The company explained that the

Read more
28 Nov 2018 12:19

Tiziana Life Sciences Begins First-In-Human Phase 1 Trial Of Foralumab

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it began the first in-human trial of Foralumab, a treatment for autoimmune diseases.The biotechnology company said the a

Read more
20 Nov 2018 12:53

Tiziana Life Sciences Prices ADS Offering, Raises GBP3.4 Million

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has priced its underwritten public offering in the US of 442,910 American Depositary Shares representing ordinary shares in

Read more
25 Sep 2018 13:43

Tiziana Life Seeks Listing Of ADS On Nasdaq Capital Market (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has commenced underwritten public offering in the US of American Depositary Shares representing ordinary shares in the UK of

Read more
24 Sep 2018 12:37

Tiziana Half-Year Loss Unchanged; Gets US Approval For Foralumab Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday reported a flat loss in the first half of 2018 as expenses were broadly unchanged, while the biotechnology firm also announced that its

Read more
17 Aug 2018 11:39

DIRECTOR DEALINGS: Tiziana Life Chairman Associate Buys Shares

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth acquired 469,766 a

Read more
16 Aug 2018 11:47

Tiziana seeks trial for multiple sclerosis 'game changer'

(Sharecast News) - Tiziana Life Sciences on Thursday submitted an application to initiate phase one clinical trials for a new treatment of neurodegenerative diseases to the US food and drug administration.

Read more
27 Jul 2018 11:14

Tiziana Life Sciences Files For IPO Of American Depositary Shares (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday it filed a registration statement with the US Securities Exchange Commission for a proposed initial public offering of its American

Read more
16 May 2018 13:27

Tiziana Life Science Reports Progress In Milcicib Phase 2a Trial

LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC said Wednesday that the phase 2a trial of Milciclib safety and tolerability in patients with Metastatic Hepatocellular has

Read more
19 Apr 2018 14:44

Tiziana Raises GBP825,000 Through Placing Of 1 Million Shares (ALLISS)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Thursday it has raised GBP825,000 from the issue of 1.0 million new shares at a price of 80 pence per share.The cancer and autoimmune

Read more
4 Apr 2018 12:53

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined

Read more
16 Nov 2016 09:34

Tiziana Life Sciences makes breakthrough oral treatment for inflammatory diseases

(ShareCast News) - Tiziana Life Sciences, the clinical stage biotechnology company, announced that new data has demonstrated the potential of its novel oral therapy with foralumab for non-alcoholic steatohepatitis (NASH), diabetes and other life threatening inflammatory diseases. Oral efficacy in hu

Read more
18 Jul 2016 12:03

Tiziana Life looks for secrets of long life with new acquisition

(ShareCast News) - Tiziana Life Sciences has purchased key assets from Sardinia-based biobanking and genomics research company Shardna for €258,000, giving it access to the genetic data of nearly 13,000 people from the Ogliastra region, where life expectancy is high. The AIM-listed clinical stage bi

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.